Investor Relations

Press Releases

March 28, 2026

Press Release: AAD: new results from Sanofi's amlitelimab phase 3 studies in atopic dermatitis presented in late-breaking research session

Read the Press Release

March 27, 2026

Press Release: Sanofi’s Sarclisa subcutaneous formulation administered via on-body injector recommended for EU approval by the CHMP to treat multiple myeloma

Read the Press Release

March 24, 2026

Press release: Availability of the Q1 2026 aide-mémoire

Read the Press Release

See more press releases

Upcoming Events

24Mar

2026

BNP Paribas Healthcare Conference – London

Conferences

26Mar

2026

Goldman Sachs 9th Annual Biopharma Innovation Summit – London

Conferences

23Apr

2026

First quarter 2026

Q1 2026 results will be reviewed by management during a live audio webcast with the financial community on April 23, 2026. The presentation will be followed by a Q&A session.

13:00 - 14:00 CET (7:00am - 8:00am EST)

Quarterly results

Discover more

All our events

Female scientist in white lab coat and safety equipment working with a tablet at a laboratory workstation with protective hood

Shuang Yang, Scientist, China

2025 20-F

Presenting our 2025 FORM 20-F.

30th Consecutive Year of Dividend Increase

Learn more

Dr. Yohana Mokiwa has a serious expression, blue shirt and stethoscope, as he speaks with a patient in a pop up clinic

Dr. Yohana Mokiwa speaking with a patient in a pop-up clinic, Dar es Salaam, Tanzania

Environment, Social, Governance

As a global pharmaceutical company, we stretch everyday to deliver safe and sustainable innovation and play our part in addressing some of the world’s most pressing challenges.